# Topical Bromfenac for Intraoperative Miosis and Pain Reduction

> **NCT03831984** · PHASE4 · UNKNOWN · sponsor: **Hospital de La Luz** · enrollment: 60 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** 0,09% Bromfenac
- **DRUG:** 0,1% sodium hyaluronate

## Key facts

- **NCT ID:** NCT03831984
- **Lead sponsor:** Hospital de La Luz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2018-11-30
- **Final completion:** 2019-03-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831984, "Topical Bromfenac for Intraoperative Miosis and Pain Reduction". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT03831984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*